3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
252
INDUSTRY
238
NIH
31
OTHER_GOV
11
NETWORK
6
UNKNOWN
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Thoracic
2
Lymphoid
2
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Platinum-resistant Recurrent Ovarian Cancer
1
Papillomavirus Infections
1
Neoplasms
1
Melanoma
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Neoplasms
×
Gynecologic
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled